Experimental melanin-induced uveitis: Experimental model of human acute anterior uveitis

Ophthalmic Research

Volumn 40, Issue 3-4, 2008, Pages 136-140

  Smith, Justine R ^a   Rosenbaum, James T ^a,b   Williams, Keryn A ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Experimental melanin induced uveitis; Human acute anterior uveitis

Indexed keywords

AMINOGUANIDINE; CD4 ANTIBODY; CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; MELANIN; NITRIC OXIDE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ACUTE DISEASE; ANTERIOR EYE CHAMBER; APOPTOSIS; BIOLOGICAL THERAPY; BIOMICROSCOPY; CD4+ T LYMPHOCYTE; CELL SUBPOPULATION; CHOROIDITIS; CLINICAL FEATURE; COMPLEMENT SYSTEM; CONVALESCENCE; DISEASE DURATION; DISEASE MODEL; DISEASE SEVERITY; EMPYEMA; EXPERIMENTAL MODEL; EYE INFLAMMATION; FIBRIN CLOT; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNIZATION; INBRED STRAIN; IRIDOCYCLITIS; LEUKOCYTE MIGRATION; NONHUMAN; OUTBRED STRAIN; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SLIT LAMP; UVEITIS; VIRAL GENE THERAPY;

ACUTE DISEASE; ANIMALS; ANTERIOR CHAMBER; CD4-POSITIVE T-LYMPHOCYTES; CILIARY BODY; DISEASE MODELS, ANIMAL; HUMANS; IRIS; MELANINS; RATS; RATS, INBRED F344; UVEITIS, ANTERIOR; VITREOUS BODY;

EID: 42449134976     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119864     Document Type: Review

References (42)

1. Broekhuyse RM, Kuhlmann ED, Winkens HJ, Van Vugt AH: Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble, intrinsic protein fraction of the retinal pigment epithelium. Exp Eye Res 1991;52:465-474.
2. Broekhuyse RM, Kuhlmann ED, Winkens HJ: Experimental autoimmune anterior uveitis (EAAU). II. Dose-dependent induction and adoptive transfer using a melaninbound antigen of the retinal pigment epithelium. Exp Eye Res 1992;55:401-411.
3. Broekhuyse RM, Kuhlmann ED, Winkens HJ: Experimental autoimmune anterior uveitis (EAAU). III. Induction by immunization with purified uveal and skin melanins. Exp Eye Res 1993;56:575-583.
4. Chan CC, Hikita N, Dastgheib K, Whitcup SM, Gery I, Nussenblatt RB: Experimental melanin-protein-induced uveitis in the Lewis rat. Immunopathologic processes. Ophthalmology 1994;101:1275-1280.
5. Bora NS, Kim MC, Kabeer NH, et al: Experimental autoimmune anterior uveitis: Induction with melanin-associated antigen from the iris and ciliary body. Invest Ophthalmol Vis Sci 1995;36:1056-1066.
6. Bora NS, Sohn JH, Kang SG, et al: Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J Immunol 2004;172:7086-7094.
7. Rothova A, van Veenedaal WG, Linssen A, Glasius E, Kijlstra A, de Jong PT: Clinical features of acute anterior uveitis. Am J Ophthalmol 1987;103:137-145.
8. Smith JR, Hart PH, Parish CR, Standfield SD, Coster DJ, Williams KA: Experimental melanin-induced uveitis in the Fischer 344 rat is inhibited by anti-CD4 monoclonal antibody, but not by mannose-6-phosphate. Clin Exp Immunol 1999;115:64-71.
9. Broekhuyse RM, Winkens HJ, Kuhlmann ED: Multiple recurrences in melanin-protein-induced uveitis in the rat. Ocul Immunol Inflamm 1995;3:149-155.
10. Rosenbaum JT: Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am 1992;18:143-151.
11. Wakefield D, Montanaro A, McCluskey P: Acute anterior uveitis and HLA-B27. Surv Ophthalmol 1991;36:223-232.
12. Chan CC, Dastgheib K, Hikita N, Walton RC, Nussenblatt RB, Broekhuyse RM: Experimental melanin-protein induced uveitis ('EMIU', formerly 'EAAU'): immunopathology, susceptibility and therapy; in Nussenblatt RB, Whitcup SM, Caspi RR, Gery I (eds): Advances in Ocular Immunology. Amsterdam, Elsevier Science, 1994, pp 91-94.
13. Broekhuyse RM, Winkens HJ, Kuhlmann ED: Intraperitoneally injected melanin is highly uveitogenic. Exp Eye Res 1996;62:199-200.
14. Broekhuyse RM, Kuhlmann ED, Winkens HJ: Experimental melanin-protein induced uveitis (EMIU) is the sole type of uveitis evoked by a diversity of ocular melanin preparations and melanin-derived soluble polypeptides. Jpn J Ophthalmol 1996;40:459-468.
15. Bora NS, Woon MD, Tandhasetti MT, Cirrito TP, Kaplan HJ: Induction of experimental autoimmune anterior uveitis by a self-antigen: melanin complex without adjuvant. Invest Ophthalmol Vis Sci 1997;38:2171-2175.
16. Smith JR, O'Rourke LM, Becker MD, et al: Anti-rat ICAM-1 antibody does not influence the course of experimental melanin-induced uveitis. Curr Eye Res 2000;21:906-912.
17. Kim MC, Kabeer NH, Tandhasetti MT, Kaplan HJ, Bora NS: Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res 1995;14:703-710.
18. Baatz H, Puchta J, Reszka R, Pleyer U: Macrophage depletion prevents leukocyte adhesion and disease induction in experimental melanin-protein induced uveitis. Exp Eye Res 2001;73:101-109.
19. Li Q, Dastgheib K, Luyo D, Egwuagu C, Nussenblatt RB, Chan CC: Expression of transforming growth factor β1 (TGFβ1) in experimental melanin protein induced uveitis and experimental autoimmune uveitis; in Nussenblatt RB, Whitcup SM, Caspi RR (eds): Advances in Ocular Immunology. Amsterdam, Elsevier Science, 1994, pp 99-102.
20. Li Q, Sun B, Matteson DM, O'Brien TP, Chan CC: Cytokines and apoptotic molecules in experimental melanin-protein induced uveitis (EMIU) and experimental autoimmune uveoretinitis (EAU). Autoimmunity 1999;30:171-182.
21. Woon MD, Kaplan HJ, Bora NS: Kinetics of cytokine production in experimental autoimmune anterior uveitis (EAAU). Curr Eye Res 1998;17:955-961.
22. Kim HS, Yoon SK, Joo CK: The expression of multiple cytokines and inducible nitric oxide synthase in experimental melanin-protein-0induced uveitis. Ophthalmic Res 2001;33:329-335.
23. Santos Lacomba M, Marcos Martin C, Gallardo Galera JM, et al: Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 2001;33:251-255.
24. El-Shabrawi Y, Hermann J: Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology 2002;109:2342-2346.
25. Martin CM, Lacomba MS, Molina CI, Chamond RR, Galera JM, Estevez EC: Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients. Curr Eye Res 2000;20:287-292.
26. Fang IM, Yang CH, Lin CP, Yang CM, Chen MS: Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res 2004;78:1043-1055.
27. Fang IM, Lin CP, Yang CM, Chen MS, Yang CH: Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis. Mol Vis 2005;11:443-451.
28. Verma MJ, Lloyd A, Rager H, et al: Chemokines in acute anterior uveitis. Curr Eye Res 1997;16:1202-1208.
29. Smith JR, Hart PH, Standfield SD, Coster DJ, Wing SJ, Williams KA: Apoptosis is a prominent feature of acute anterior uveitis in the Fischer 344 rat. Br J Ophthalmol 2000;84:205-211.
30. Yilmaz G, Sizmaz S, Yilmaz ED, Duman S, Aydin P: Aqueous humor nitric oxide levels in patients with Behçet disease. Retina 2002;22:330-335.
31. Dick AD, Siepmann K, Dees C, et al: Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis. Invest Ophthalmol Vis Sci 1999;40:2258-2267.
32. Curnow SJ, Scheel-Toellner D, Jenkinson W, et al: Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling. J Immunol 2004;173:5290-5297.
33. Yu HG, Chung H, Lee WJ: Apoptosis of CD4+ T cells occurs in experimental autoimmune anterior uveitis (EAAU). Clin Exp Immunol 1999;118:357-363.
34. Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS: Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci 2000;41:4195-4202.
35. Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS: Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci 2000;41:3492-3502.
36. Jha P, Sohn JH, Xu Q, et al: The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 2006;47:1030-1038.
37. Jha P, Sohn JH, Xu Q, et al: Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J Immunol 2006;176:7221-7231.
38. Shao H, Woon MD, Nakamura S, et al: Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 2001;42:2016-2021.
39. Fang IM, Lin CP, Yang CH, et al: Inhibition of experimental autoimmune anterior uveitis by adenovirus-mediated transfer of the interleukin-10 gene. J Ocul Pharmacol Ther 2005;21:420-428.
40. Uchio E, Kijima M, Tanaka S, Ohno S: Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1. Invest Ophthalmol Vis Sci 1994;35:2626-2631.
41. Matteson DM, Shen DF, Chan CC: Inhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C. J Autoimmun 1999;13:197-204.
42. Bora NS, Sohn JH, Bora PS, Kaplan HJ, Kulkarni P: Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU). Ocul Immunol Inflamm 2005;13:183-189.